Hoth Therapeutics, a biotechnology company, has decided to invest $1 million into Bitcoin, marking a significant move in corporate treasury management. This decision underscores the increasing trend among businesses to adopt Bitcoin as a hedge against inflation.
The move by Hoth Therapeutics reflects a broader acceptance and recognition of Bitcoin’s potential as a store of value, especially in uncertain economic times.
This investment decision indicates growing confidence in Bitcoin's long-term value proposition, as more companies explore diversifying their treasury assets with cryptocurrency.
![[이주의 암호화폐 이슈] 게리 겐슬러 사임 예고, 암호화폐 차르 등](https://loutre.blockchair.io/w4/storage/news/9it7df7zkfvet4lj.png){kind=small}
